The next €1B flagship projects will target ICT, energy and health, according to the draft work programme for 2018-2020 published by the Commission

Health insurers and pharma companies are striking pay-for-results deals under which rebates are offered if a drug does not perform as well in the real world as in clinical trials

Paying hospitals for activity provides no incentive to improve. Using historical data, patients awaiting cardiac surgery can be profiled, with hospitals paid extra to bear the risk of complications, but receiving no further payment if a second operation is required

The German government has pledged €51.35 million as part of a €56.5 million funding. Other countries and foundations are donating the balance, to advance the work of the Global Antibiotic Research and Development Partnership